BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home » Authors » Randy Osborne

Articles by Randy Osborne

Panel Favors Genzyme Over TKT In Fabry Race Fraught With Irony

Jan. 20, 2003
By Randy Osborne
Look up the origins of the word "enzyme" in the dictionary and you'll find it has a possible Greek root, related to the word "juice." Look up "juice," and you'll find that it can be defined as "strength, vigor, vitality" - words seldom associated with the biotechnology sector these days. (BioWorld Financial Watch)
Read More

FDA Stops Gene Therapy Trials; Second French Patient Leukemic

Jan. 16, 2003
By Randy Osborne

BioFocus Enters Amgen Deal, Offers Warning On Financials

Jan. 15, 2003
By Randy Osborne

Durect, Pain Therapeutics Sign Deal For Longer-Acting Opioids

Jan. 15, 2003
By Randy Osborne

Aventis Picks Five Eos Targets; Vaccine Deal Ends With 'Bang'

Jan. 14, 2003
By Randy Osborne

BioFocus Enters Amgen Deal, Offers Warning On Financials

Jan. 14, 2003
By Randy Osborne

SBI, GeneFormatics Merger Mix Of Technologies, Drugs - And Cash

Jan. 13, 2003
By Randy Osborne
In these hard economic times, when you hear anybody in biotechnology say it's "not all about cash," you might suspect the speaker of being na ve or disingenuous. And when such words come out of the straitened genomics sector, they sound even much more suspicious. (BioWorld Financial Watch)
Read More

Chiron, GSK Enter Agreement For Obesity Pathway Research

Jan. 9, 2003
By Randy Osborne
Several months after the company cut three late-stage programs, Chiron Corp. has set about the business of building its pipeline, nailing down a small-molecule partnership with GlaxoSmithKline plc to fuel research in the melanocortin 4 receptor pathway. (BioWorld Today)
Read More

Cephalon, MDS Sign Agreement On Proteomics-Based Research

Jan. 8, 2003
By Randy Osborne

SBI, GeneFormatics Merging To Push Drug Development

Jan. 7, 2003
By Randy Osborne
Previous 1 2 … 441 442 443 444 445 446 447 448 449 … 465 466 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 14, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 14, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing